Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FY9PD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,294
Award facts
- Contract value 100% obligated
- $17,294.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,294.03 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials, with performance to be completed by August 20, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The underlying IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The firm's federal contract portfolio demonstrates extensive capability in fulfilling diverse pharmaceutical requirements, from specialty medications and brand-name drugs to vaccines and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FY9PD?
SPE2DB25FY9PD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FY9PD worth?
The government has obligated $17,294 on SPE2DB25FY9PD.
Is contract SPE2DB25FY9PD an order under another contract?
Yes. SPE2DB25FY9PD is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9PD competed?
The extent of competition for SPE2DB25FY9PD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award